Neoplasms, Hematologic
Oncology·MeSH: Myelodysplastic Syndromes
1 drug in development·1 company·2 clinical trials
Drug Pipeline by Phase
Phase 2(1)
| Drug | Company |
|---|---|
| 120 mg ly2784544 | ELI LILLY & Co (LLY) |
Frequently asked questions
How many drugs are in development for Neoplasms, Hematologic?
BioSniper tracks 1 drug in development for Neoplasms, Hematologic across 1 company.
How many clinical trials target Neoplasms, Hematologic?
There are 2 clinical trials targeting Neoplasms, Hematologic tracked by BioSniper.
Deep-dive into Neoplasms, Hematologic
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis